Know Cancer

or
forgot password
  • cancer clinical trials in san antonio, TX

  • Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Veterans Affairs Medical Center - San Antonio (Murphy)
    Cancer Therapy and Research Center
    University Hospital - San Antonio
    Bladder Cancer
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Methodist Children's Hospital of South Texas
    San Antonio, Texas 78229-3993
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Inflammatory Breast Cancer (IBC) Registry
    UT Health Science Center - San Antonio
    San Antonio, Texas 78229
    Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    San Antonio Tumor and Blood Clinic

    Trial Locations
    San Antonio Tumor and Blood Clinic
    HOAST-Medical Dr.
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    HOAST-Medical Dr.
    San Antonio, Texas 78229
    Breast Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Neuroblastoma
    Vaccine Therapy in Treating Patients With Breast Cancer
    STOH Clinical Research
    San Antonio, Texas 78229
    Breast Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    HOAST - Medical Dr.
    San Antonio, Texas 78229
    Rectal Cancer
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Cancer Centers of South Texas - HOAST
    San Antonio, Texas 78229
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
    South Texas Accelerated Research Therapeutics (START)
    San Antonio, Texas 78229
    Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Extraocular Retinoblastoma
    A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
    UTHSC- CTRC and Institute for Drug Development
    San Antonio, Texas 78229
    Advanced and/or Metastatic Solid Organ Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Cancer Care Centers of South Texas - Northeast
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Audie L Murphy Veterans Affairs Hospital
    University Hospital
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Audie L Murphy Veterans Affairs Hospital

    Trial Locations
    Audie L Murphy Veterans Affairs Hospital
    University Hospital
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
    University of Texas Health Science Center
    San Antonio, Texas 78284
    Hepatocellular Carcinoma
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Methodist Hospital (Texas Transplant)
    San Antonio, Texas 78229
    Hepatic Veno-Occlusive Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Lung Cancer
    Lifestyle Intervention for Heart Failure
    The University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78229
    Heart Failure
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Cancer Care Centers of South Texas
    San Antonio, Texas 78229
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Southwest Oncology Group (SWOG) Research Base
    San Antonio, Texas 78245
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Childhood Atypical Teratoid/Rhabdoid Tumor
    A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
    Southwest Texas Addiction Research And Tech (Start) Center
    San Antonio, Texas 78229
    Hedgehog Pathway, Smoothened, Basal Cell Carcinoma (BCC), Basal Cell Nevoid Syndrome (BCNS)
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Methodist Children's Hospital of South Texas
    San Antonio, Texas 78229-3993
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Safety Study of CALAA-01 to Treat Solid Tumor Cancers
    START (South Texas Accelerated Research Therapeutics)
    San Antonio, Texas 78229
    Cancer, Solid Tumor
    Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Retinoblastoma
    Continuous Glucose Monitoring in Critically Ill
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Diabetes
    Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
    Cancer Therapy Reasearch Center at UTHSCA
    San Antonio, Texas 78229
    Refractory TdT-Positive Leukemia
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Cancer Care Centers of South Texas / HOAST CCC of So.TX- Medical Center
    San Antonio, Texas 78229
    Myelogenous Leukemia, Chronic
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia